SG11201508374SA - Method of viral inhibition - Google Patents

Method of viral inhibition

Info

Publication number
SG11201508374SA
SG11201508374SA SG11201508374SA SG11201508374SA SG11201508374SA SG 11201508374S A SG11201508374S A SG 11201508374SA SG 11201508374S A SG11201508374S A SG 11201508374SA SG 11201508374S A SG11201508374S A SG 11201508374SA SG 11201508374S A SG11201508374S A SG 11201508374SA
Authority
SG
Singapore
Prior art keywords
viral inhibition
viral
inhibition
Prior art date
Application number
SG11201508374SA
Inventor
Johanna Elisabeth Fraser
David Andrew Jans
Kylie Michelle Wagstaff
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013901525A external-priority patent/AU2013901525A0/en
Application filed by Univ Monash filed Critical Univ Monash
Publication of SG11201508374SA publication Critical patent/SG11201508374SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
SG11201508374SA 2013-04-16 2014-04-16 Method of viral inhibition SG11201508374SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013901525A AU2013901525A0 (en) 2013-04-16 Method of viral inhibition
PCT/AU2014/050017 WO2014169355A1 (en) 2013-04-16 2014-04-16 Method of viral inhibition

Publications (1)

Publication Number Publication Date
SG11201508374SA true SG11201508374SA (en) 2015-11-27

Family

ID=51730617

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201508374SA SG11201508374SA (en) 2013-04-16 2014-04-16 Method of viral inhibition
SG10202011533PA SG10202011533PA (en) 2013-04-16 2014-04-16 Method of Viral Inhibition
SG10201708272SA SG10201708272SA (en) 2013-04-16 2014-04-16 Method of Viral Inhibition

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG10202011533PA SG10202011533PA (en) 2013-04-16 2014-04-16 Method of Viral Inhibition
SG10201708272SA SG10201708272SA (en) 2013-04-16 2014-04-16 Method of Viral Inhibition

Country Status (6)

Country Link
US (3) US11007160B2 (en)
AU (3) AU2014253607B2 (en)
BR (1) BR112015026243B1 (en)
CA (1) CA2945825C (en)
SG (3) SG11201508374SA (en)
WO (1) WO2014169355A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201508374SA (en) 2013-04-16 2015-11-27 Univ Monash Method of viral inhibition
US10406127B2 (en) 2014-07-25 2019-09-10 Laurent Pharmaceuticals Solid oral formulation of fenretinide
AU2015292212B2 (en) 2014-07-25 2019-03-14 Laurent Pharmaceuticals Solid oral formulation of fenretinide
CA3046504A1 (en) 2016-12-15 2018-06-21 Meharry Medical College Antiviral agents
US20230372310A1 (en) * 2020-10-15 2023-11-23 Baden-Württemberg Stiftung Gmbh Flavi-Block: A Pan-Flavivirus Inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60234024D1 (en) 2001-05-29 2009-11-26 Chebigen Co Ltd NEW RETINOID DERIVATIVES AND A PHARMACEUTICAL ANTI-CANCER COMPOSITION CONTAINING THESE COMPOUNDS
WO2005092314A1 (en) 2004-03-18 2005-10-06 Istituto Nazionale Per Lo Studio E La Cura Del Tum 4-oxo-fenretinide, administered alone and in combination with fenretinide, as preventive and therapeutic agent for cancer
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
US20080261978A1 (en) * 2007-03-08 2008-10-23 Clark Michael P Chemokine receptor modulators
WO2009114136A2 (en) 2008-03-12 2009-09-17 Albert Einstein College Of Medicine Of Yeshiva University Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents
AU2009222557B2 (en) * 2009-06-17 2015-06-11 Monash University Modified arthropod and method of use
WO2011146933A2 (en) * 2010-05-21 2011-11-24 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Universal dengue virus sequences and methods of use
MX2015005098A (en) * 2012-10-23 2015-09-25 Univ Georgetown Flavivirus protease inhibitors.
SG11201508374SA (en) 2013-04-16 2015-11-27 Univ Monash Method of viral inhibition
WO2016011501A1 (en) * 2014-07-21 2016-01-28 Monash University Constrained proteins and uses therefor
US10406127B2 (en) * 2014-07-25 2019-09-10 Laurent Pharmaceuticals Solid oral formulation of fenretinide
AU2015292212B2 (en) * 2014-07-25 2019-03-14 Laurent Pharmaceuticals Solid oral formulation of fenretinide

Also Published As

Publication number Publication date
AU2014253607A1 (en) 2015-11-05
BR112015026243A2 (en) 2017-07-25
US20220016057A1 (en) 2022-01-20
AU2021205039A1 (en) 2021-08-12
US11752116B2 (en) 2023-09-12
CA2945825A1 (en) 2014-10-23
US20160074346A1 (en) 2016-03-17
AU2019213440B2 (en) 2021-04-22
AU2014253607B2 (en) 2019-05-16
AU2021205039B2 (en) 2023-07-13
US11007160B2 (en) 2021-05-18
US20240016767A1 (en) 2024-01-18
SG10201708272SA (en) 2017-11-29
WO2014169355A1 (en) 2014-10-23
SG10202011533PA (en) 2021-01-28
BR112015026243B1 (en) 2020-09-29
CA2945825C (en) 2022-11-15
AU2019213440A1 (en) 2019-08-29

Similar Documents

Publication Publication Date Title
IL279682A (en) Benzoquinolone inhibitors of vmat2
HK1221466A1 (en) Bipyrazole derivatives as jak inhibitors jak
GB201401248D0 (en) Method of manufacture
HK1216429A1 (en) Methods for purification of rylsulfatase
GB201410735D0 (en) Method of inhibiting DYRK1B
EP3632467C0 (en) Inhibitors of complement factor h
HK1222339A1 (en) Inhibitors of metallo-ss-lactamase-enzymes --
HK1221645A1 (en) Benzoquinolone inhibitors of vmat2 vmat2
IL240763B (en) Halogenopyrazoles as inhibitors of therombin
EP2981374A4 (en) Method of casting
SG10202011533PA (en) Method of Viral Inhibition
GB201322931D0 (en) Method of etching
GB201305231D0 (en) Method of Manufacture
IL241096A0 (en) Method of treatment
GB2518928B (en) Method of depilation
HK1216419A1 (en) Method of synthesis
EP2968557A4 (en) Enhancement of vaccines
AU2013901525A0 (en) Method of viral inhibition
GB201311291D0 (en) Method of manufacture
GB201301262D0 (en) Method of manufacture
GB201316154D0 (en) Method of preventing corrosion
PL3071575T3 (en) Preparation of normorphinans
GB201322778D0 (en) Method of treatment
GB201314882D0 (en) Method of treatment
GB201319952D0 (en) Methods of isolating ions